Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Artificial Intelligence Final Text Confirmed By Parliament Committees

Medtechs watch on to gauge impact

Executive Summary

The “first AI Act in the world” was adopted with an overwhelming majority by European Parliament Committees IMCO and LIBE.

You may also be interested in...

How The EU & UK’s Contrasting Approaches To AI Regulation Could Impact Pharma

While EU preparations are underway to introduce strict legal requirements for all AI systems, the UK has doubled down on its flexible, non-regulatory framework. In this second of a two-part article, a lawyer explains the pros and cons of each for pharma and medtech firms.

Speculation Over Threat To EU’s AI Act Adoption Timelines Looks Unfounded

EU member states have raised concerns over the EU AI Act. However, opposition is faltering and unlikely to prevent its adoption.

New EU AI Innovation Package Launched, With AI Office

The EU’s AI innovation package offers funding, training and bespoke initiatives to support AI start-ups and SMEs. The Artificial Intelligence Office has been introduced as part of the package.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts